Exploratory investigation of changes in blood transcriptome following mepolizumab treatment for asthma - Scorecard - MDSpire

Exploratory investigation of changes in blood transcriptome following mepolizumab treatment for asthma

  • By

  • Mitchell Pitlick

  • Mrunal K. Dehankar

  • Chantal E. McCabe

  • Sergio E. Chiarella

  • Kathleen Bartemes

  • Kay A. Bachman

  • Chung-Il Wi

  • Young J. Juhn

  • Thanai Pongdee

  • June 15, 2026

  • 0 min

Share

Clinical Scorecard: Investigation of Blood Transcriptome Alterations Following Mepolizumab Therapy in Severe Eosinophilic Asthma Patients

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients diagnosed with Severe Eosinophilic Asthma with absolute blood eosinophil count ≥ 300/mm3, as per study criteria.
Care Setting

Key Highlights

  • additional_info

Guideline-Based Recommendations

Diagnosis

    Management

    • S
    • p
    • e
    • c
    • i
    • f
    • y
    • d
    • o
    • s
    • i
    • n
    • g
    • a
    • n
    • d
    • a
    • d
    • m
    • i
    • n
    • i
    • s
    • t
    • r
    • a
    • t
    • i
    • o
    • n
    • d
    • e
    • t
    • a
    • i
    • l
    • s
    • f
    • o
    • r
    • m
    • e
    • p
    • o
    • l
    • i
    • z
    • u
    • m
    • a
    • b
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Clinical Best Practices

        • follow_up

        Related Resources & Content

        Original Source(s)

        Exploratory investigation of changes in blood transcriptome following mepolizumab treatment for asthma

        • by Mitchell Pitlick, Mrunal K. Dehankar, Chantal E. McCabe, Sergio E. Chiarella, Kathleen Bartemes, Kay A. Bachman, Chung-Il Wi, Young J. Juhn, Thanai Pongdee

        • June 15, 2026

        Related Content

        Paradoxical enrichment of Akkermansia in children with poorly controlled asthma: a longitudinal study

        Fibrinogen-like protein 2 regulates inflammatory and metabolic reprogramming of airway smooth muscle cells through PI3K/Akt activation

        Bone health in asthma: a twofold effect of disease and pharmacotherapy